Skip to Main Content

Clinical Studies and Protocols

Site Map Investigators Log-in
(BRO-0905) Human immune response to yellow fever vaccination


 Return to List of Clinical Studies
 Return to List of Protocols for Immunology
Single cell transcriptomics for characterizing the human immune response to yellow fever vaccination

Principal Investigator:
Brad Rosenberg MD, PhD

Investigators:

Contact Information:
Recruitment Specialist
1230 York Avenue
New York, NY 10065
Telephone: 1-800-RUCARES
Alt. Telephone: 1-800-782-2737
Email: RUCARES@rockefeller.edu
Enrollment Status:
Open to Enrollment

Brief Summary of Protocol:
The immune system is composed of diverse cell types with different functions that act together in order to defend against infection. This pilot study will test a new technology for studying these many different cell types at very large numbers at the level of individual cells. This method will then be used to identify the cell types and functions important for the immune response to the highly protective yellow fever vaccine, which will improve our understanding of effective vaccine features.



Detailed Description of Protocol:




What specifically makes a person eligible for the study?
You may be eligible to enter this study:

- Willing to Receive Yellow Fever Vaccine - Up to 6 visits to Rockefeller University

Gender:
Both

Age(s):
18-59 years old

Children permitted to participate:
No

Potential Benefits.....
No known benefits at this time



Compensation:
Compensation is provided